NIBR in the News

28 December 2014
Malaria: Real and present danger
Financial Times, Michael Peel and Andrew Ward

December 25, 2014
Long-used medications may have anti-aging effects
USA Today, Karen Weintraub

December 10. 2014
Novartis and Roche leaders in R&D
European BioTechnology

December 8, 2014
Novartis adds to CAR-Ts luster with more excellent cancer data
Fierce Biotech

November 17, 2014
Novartis revs up a promising pharmacoeconomic case for heart failure drug LCZ696
John Carroll, Fierce

November 11, 2014
Lab-Grown Neurons From Autistic Kids Could Lead to New Treatment
Greg Miller, Wired

November 6, 2014
Drugmakers look to push the limits of old age
Caroline Copley, Reuters

October 21, 2014
Boston’s Life Science Disruptors: The Photos
Ben Fidler

October 21, 2014
Cellular Immunotherapy & Unum Therapeutics: Out Of Many, One (Novartis mentioned)

October 20, 2014
GNF Gerald F. Joyce elected to the Institute of Medicine at the National Academy of Sciences

October 14, 2014
Everyday drugs could give extra years of life
Clare Wilson, The New Scientist

September 30, 2014
Planning a Center for Advanced Cellular Therapeutics at Penn
Univ. of Pennsylvania Almanac

September 28, 2012
Big Pharma Ramps Up Postdoc Programs (NIBR Featured)
Michael Price, Science

September 22, 2014
[VIDEO] Novartis Studies Muscle Atrophy by Sending Mice into Space
Global Healthcare

September 19, 2014
Mousetronauts To Live In Space For the Longest Stretch Yet
Popular Science

September 2, 2014
Lack of Initiative in drug discovery ails India (Dhaval Patel quoted)
Economic Times of India

September 1, 2014
Most exciting ever' Novartis drug points to huge sales (Strong R & D mentioned)

September 2014
Flow Cytometry Powers High-Throughput Screening Advances
Society for Lab Automation and Screening

June 26, 2014
Keys to the Car (Seth Ettenberg quoted)
Tracey Baas, SciBx

June 17, 2014
Shining Light on Madness
Technology Review, David Rotman

June 14, 2014
Life Sciences Technologies: Big Biological impacts from big data (Stephen Cleaver quoted)

April 27, 2014
Drugs Aim to Help Elderly Rebuild Muscle
Marta Falconi, Wall Street Journal

April 23, 2014
Deaf people get gene tweak to restore natural hearing
Helen Thomson, New Scientist

April 7, 2014
Carnegie Mellon presents Ricardo Dolmetsch with Carnegie Prize in Mind and Brain Sciences
Carnegie Mellon University

April 7, 2014
Sound Science (Novartis atonal gene therapy trials mentioned)
Lisa Jarvis, Chemical and Engineering News

January 29, 2014
Novartis races to the FDA with its 'breakthrough' lung cancer drug
Fierce BioTech

January 12, 2014
Harvard Square Draws Deal-Seeking Drugmakers From Europe
Naomi Kresge, Bloomberg Businessweek